Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-07-27 00:00:00 ET · period of report 2022-07-25 · accession 0000899243-22-026840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-27 | 2022-07-25 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale+OE | $281.38 | -132.1K | 2,423 | -98% | -$37.16M |
| D | 2022-07-27 | 2022-07-25 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | M - OptEx | $91.05 | +60.3K | 134.5K | +81% | +$5.49M |
| D | 2022-07-27 | 2022-07-25 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | M - OptEx | $0.00 | -60.3K | 33.5K | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-25 | S | D | 40,666 | $282.43 | 12,894 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89). |
| 2 | Common | Common Stock | 2022-07-25 | S | D | 34,090 | $281.27 | 53,560 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89). |
| 3 | Common | Common Stock | 2022-07-25 | S | D | 32,983 | $280.37 | 87,650 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88). |
| 4 | Common | Common Stock | 2022-07-25 | S | D | 13,869 | $279.44 | 120,633 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89). |
| 5 | Common | Common Stock | 2022-07-25 | M | A | 60,342 | $91.05 | 134,502 | D | — | — | |
| 6 | Common | Common Stock | 2022-07-25 | S | D | 10,471 | $283.42 | 2,423 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84). |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-07-25 | M | D | 60,342 | $0.00 | 33,524 | D | $91.05 · — to 2026-02-01 | 60,342 Common Stock | (F8) Fully vested. |